Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticancer potential of nitric oxide (NO) in neuroblastoma treatment

RSC Advances(2021)10.1039/d1ra00275aSource: DataRank Database

Anticancer potential of nitric oxide (NO) in neuroblastoma treatment is a research paper published in RSC Advances (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

ensembl

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.04)OA: goldTopics (16)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kristin J. Hinsen,Melissa M. Reynolds ORCID,Tyler A. Smith ORCID,Haley O. Tucker ORCID,Mark A. Brown ORCID

Live enrichment

PubMed:35423416 PMC:PMC8695301 OpenAlex:https://openalex.org/W3133670520

Cancer Prevention and Research Institute of Texas

Grant: RP100612

Cancer Prevention and Research Institute of Texas

Grant: RP120348

National Institutes of Health

Grant: R01CA31534

NCI NIH HHS

Grant: R01 CA031534

National Institutes of Health

Grant: 5R01CA031534-06

ISOTYPE SWITCHING IN A NEOPLASTIC B CELL MODEL BCL 1

Colorado State University

FWCI

1.04

Citation Percentile

0.8%

Citation Trend

2021

2022

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://pubs.rsc.org/en/content/articlepdf/2021/ra/d1ra00275a

publisherhttps://pubs.rsc.org/en/content/articlepdf/2021/ra/d1ra00275a

publisherhttp://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA00275A

journalhttps://doi.org/10.1039/d1ra00275a

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35423416

Fields of Study

Neuroblastoma Research and TreatmentsIon channel regulation and functionCancer, Hypoxia, and Metabolism0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

NeuroblastomaNitric oxideChemistryPharmacologyCombinatorial chemistryCancer researchMedicineOrganic chemistryBiologyGenetics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalities

Anticancer potential of nitric oxide (NO) in neuroblastoma treatment

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)